Egis in the World

Our products are available in 61 countries

Click here to learn more

Pharma Company

Egis activities extend to every field of the pharmaceutical value chain

Click here to learn more

Research & Development

One of the fundamental pillars of our strategy is innovation. We devoted approximately EUR 45 million to research and development in the 2020/2021 financial year.

Click here to learn more
Own subsidiaries / Representative offices
Sales through Partners

Egis in the World

Egis is present in 61 countries with its products.

Our portfolio consists of almost 634 products. Our main focus lies on treating diseases of the cardiovascular and central nervous systems.

Learn more

A place to work

Join us!

Healthcare Professionals

and prescription drugs

Professional content for our medical and pharmaceutical visitors. The information in this section is for healthcare specialists only!

Learn more
Main therapic areas
Main therapic areas
Allergology
Anti inflammatory
Cardiovascular system
Central nervous system
Diabetology
Gastroenterology
Oncology
Women´s health
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox